Capricor Therapeutics Inc (NASDAQ:CAPR) price on Thursday, February 27, fall -0.55% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.38.
A look at the stock’s price movement, the close in the last trading session was $14.46. Turning to its 52-week performance, $23.40 and $3.52 were the 52-week high and 52-week low respectively. Overall, CAPR moved 1.05% over the past month.
Capricor Therapeutics Inc’s market cap currently stands at around $653.85 million, with investors looking forward to this quarter’s earnings report slated for in March.
The average forecast suggests down to a -18.35% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 20.97M, representing a -16.70% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CAPR is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CAPR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CAPR’s current price about -2.99% and 0.84% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.47, while 7-day volatility ratio is 10.05% and 7.63% in the 30-day chart. Further, Capricor Therapeutics Inc (CAPR) has a beta value of 4.12, and an average true range (ATR) of 1.15. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $10 and high of $21.5. Looking at the price targets, the low is 30.46% off current price level while to achieve the yearly target high, price needs to move -49.51%. Nonetheless, investors will most likely welcome a -4.31% jump to $15 which is the analysts’ median price.
If we refocus on Capricor Therapeutics Inc (NASDAQ:CAPR), historical trading data shows that trading volumes averaged 1.18 million over the past 3 months. The company’s latest data on shares outstanding shows there are 40.33 million shares.
The 12.08% of Capricor Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 39.05% of the company’s shares. Current price change has pushed the stock 4.20% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CAPR stock continues to rise going into the next quarter.
